APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 78 filers reported holding APPLIED MOLECULAR TRANS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,949 | -40.8% | 139,808 | -2.6% | 0.00% | – |
| Q2 2023 | $37,051 | -19.4% | 143,609 | 0.0% | 0.00% | – |
| Q1 2023 | $45,954 | +76490.0% | 143,609 | 0.0% | 0.00% | – |
| Q4 2022 | $60 | -100.0% | 143,609 | -6.7% | 0.00% | – |
| Q3 2022 | $149,000 | -70.7% | 153,870 | -12.0% | 0.00% | – |
| Q2 2022 | $508,000 | -81.3% | 174,863 | -51.6% | 0.00% | – |
| Q1 2022 | $2,717,000 | -46.8% | 361,369 | -1.0% | 0.00% | -100.0% |
| Q4 2021 | $5,104,000 | -41.4% | 365,117 | +8.5% | 0.00% | 0.0% |
| Q3 2021 | $8,704,000 | -48.2% | 336,490 | -8.4% | 0.00% | -50.0% |
| Q2 2021 | $16,806,000 | +19.4% | 367,439 | +14.9% | 0.00% | 0.0% |
| Q1 2021 | $14,079,000 | +98.5% | 319,905 | +38.8% | 0.00% | +100.0% |
| Q4 2020 | $7,092,000 | -4.2% | 230,509 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $7,405,000 | +1622.1% | 232,717 | +1258.4% | 0.00% | – |
| Q2 2020 | $430,000 | – | 17,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 3,611,615 | $567,024 | 70.62% |
| Founders Fund VI Management, LLC | 826,607 | $129,777 | 0.98% |
| EPIQ Capital Group, LLC | 8,689,075 | $1,364,185 | 0.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,808 | $21,949 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $78 | 0.00% |
| STATE STREET CORP | 55,055 | $8,644 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 650 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 49,958 | $7,843 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 66,207 | $10,395 | 0.00% |
| Qube Research & Technologies Ltd | 2,104 | $330 | 0.00% |